Table 3 |
|||
| Effect of Doxorubicin, Vitamin E, and Telmisartan on rat serum CK-MB in IU/L | |||
| Groups | CK-MB level IU/L | Percent of changing | |
| Before treatment | After treatment | ||
| Doxorubicin 15 mg./kg | 685.8 ± 115.4 | 4759.1 ± 137.7 †† | 594% |
| Doxo. + Vit E 100 mg./kg | 587.6 ± 116.2 | 1008.7 ± 181.9 ** | 71.7% |
| Doxo. + Telmisartan 1 mg./kg | 666.7 ± 146.1 | 1926.2 ± 155.4 ††** | 189% |
The values are expressed as mean ± SEM.† P < 0.05, †† P < 0.01 (means of each group after treatment versus their means before treatment) by using paired t test.
* P < 0.05, ** P < 0.01 (means of Vitamin E, and Telmisartan groups after treatment versus means of Doxorubicin group after treatment) by using LSD test.
Hadi et al. BMC Cardiovascular Disorders 2012 12:63 doi:10.1186/1471-2261-12-63
